Idiopathic Growth Hormone Deficiency
Idiopathic Growth Hormone Deficiency (IGHD) is a rare condition where the body does not produce enough growth hormone, leading to issues with growth and development in children and adolescents.
Growth Hormone Deficiency: LUM-201 Treatment Study
We are monitoring the long-term safety of LUM-201 in children with idiopathic growth hormone deficiency. This study also looks at how the treatment affects growth and related health markers.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Who can participate in the clinical trial?
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
- Are you between 6 and 18 years old?
- Do you have any serious medical or genetic conditions that could make using LUM-201 risky?
- Are you currently taking any medications that affect the CYP3A4 system, like certain antibiotics or antifungals?
- If you are sexually active, are you using an acceptable form of contraception?
- Have you successfully completed at least 12 months in a pediatric LUM-201 GHD study?
What experimental substances are being tested?
Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.
Lum-201
Ibutamoren
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Uniwersytecki Dzieciecy Szpital Kliniczny Im. L. Zamenhofa W Bialymstoku samodzielny publiczny zakład opieki zdrowotnej
Klinika Pediatrii, Endokrynologii, Diabetologii z Pododdziałem Kardiologii
Białystok, Poland
Instytut Centrum Zdrowia Matki Polki
Klinika Endokrynologii i Chorób Metabolicznych
Łódź, Poland
Uniwersyteckie Centrum Kliniczne Warszawskiego Uniwersytetu Medycznego
SP Dziecięcy Szpital Kliniczny w Warszawie, Klinika Pediatrii i Endokrynologii
Ochota, Poland
Sponsor: Lumos Pharma Inc.
Last updated: Nov 27, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.